Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Goodrx Holdings Inc Cl A (GDRX)

Goodrx Holdings Inc Cl A (GDRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 831,611
  • Shares Outstanding, K 339,433
  • Annual Sales, $ 792,320 K
  • Annual Income, $ 16,390 K
  • EBIT $ 164 M
  • EBITDA $ 236 M
  • 60-Month Beta 1.50
  • Price/Sales 1.13
  • Price/Cash Flow 7.45
  • Price/Book 1.34

Options Overview Details

View History
  • Implied Volatility 88.95% (-9.32%)
  • Historical Volatility 87.52%
  • IV Percentile 48%
  • IV Rank 26.75%
  • IV High 174.19% on 12/29/25
  • IV Low 57.83% on 03/05/25
  • Expected Move (DTE 22) 0.30 (14.88%)
  • Put/Call Vol Ratio 0.10
  • Today's Volume 2,402
  • Volume Avg (30-Day) 3,727
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 49,751
  • Open Int (30-Day) 52,400
  • Expected Range 1.70 to 2.30

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.06
  • Number of Estimates 3
  • High Estimate 0.08
  • Low Estimate 0.04
  • Prior Year 0.05
  • Growth Rate Est. (year over year) +20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.92 +4.17%
on 02/26/26
2.68 -25.51%
on 02/05/26
-0.52 (-20.63%)
since 01/26/26
3-Month
1.92 +4.17%
on 02/26/26
2.97 -32.66%
on 12/12/25
-0.83 (-29.33%)
since 11/26/25
52-Week
1.92 +4.17%
on 02/26/26
5.81 -65.58%
on 10/09/25
-2.89 (-59.10%)
since 02/26/25

Most Recent Stories

More News
GoodRx’s (NASDAQ:GDRX) Q4 CY2025 Sales Top Estimates But Stock Drops 11.8%

GoodRx’s (NASDAQ:GDRX) Q4 CY2025 Sales Top Estimates But Stock Drops 11.8%

GDRX : 2.01 (-17.96%)
GoodRx Reports Fourth Quarter and Full Year 2025 Results

Fourth Quarter and Full Year 2025 Revenue and Adjusted EBITDA Results In-line with Previous Guidance Pharma Direct Revenue Beats Previous Outlook with Over 40% Year-Over-Year...

GDRX : 2.01 (-17.96%)
GoodRx Expands Into Employer Market With Launch of “GoodRx Employer Direct”

New program combines employer-subsidized discounted cash prices and custom telemedicine solutions with existing health benefits to close coverage gaps and support access to high-impact medications

GDRX : 2.01 (-17.96%)
GoodRx (GDRX) Reports Earnings Tomorrow: What To Expect

GoodRx (GDRX) Reports Earnings Tomorrow: What To Expect

GDRX : 2.01 (-17.96%)
iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know

iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know

FTRE : 10.46 (+1.16%)
GDRX : 2.01 (-17.96%)
AGL : 0.5563 (+11.26%)
MYGN : 4.77 (-0.21%)
IRTC : 138.18 (+1.68%)
GoodRx (GDRX): Buy, Sell, or Hold Post Q3 Earnings?

GoodRx (GDRX): Buy, Sell, or Hold Post Q3 Earnings?

GDRX : 2.01 (-17.96%)
1 Healthcare Stock with Promising Prospects and 2 Facing Challenges

1 Healthcare Stock with Promising Prospects and 2 Facing Challenges

GDRX : 2.01 (-17.96%)
AGL : 0.5563 (+11.26%)
AZTA : 27.29 (-2.12%)
GoodRx Powers Pricing for Leading Brand Medications on TrumpRx

Brief Summary: GoodRx is a core integration partner for TrumpRx, powering the pricing for leading brand medications At launch, GoodRx is the integrated...

GDRX : 2.01 (-17.96%)
1 Oversold Stock Set for a Comeback and 2 We Brush Off

1 Oversold Stock Set for a Comeback and 2 We Brush Off

HUM : 181.57 (+3.13%)
GDRX : 2.01 (-17.96%)
BOX : 23.47 (+2.00%)
GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale

Independent assessment validates GoodRx’s continued leadership in cybersecurity and data protection

GDRX : 2.01 (-17.96%)

Business Summary

GoodRx Holdings Inc. provides consumer-focused digital healthcare platform. GoodRx Holdings Inc. is based in Santa Monica, California.

See More

Key Turning Points

3rd Resistance Point 2.65
2nd Resistance Point 2.57
1st Resistance Point 2.51
Last Price 2.01
1st Support Level 2.37
2nd Support Level 2.29
3rd Support Level 2.23

See More

52-Week High 5.81
Fibonacci 61.8% 4.32
Fibonacci 50% 3.86
Fibonacci 38.2% 3.41
Last Price 2.01
52-Week Low 1.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar